Wugen Announces Presentation of WU-NK-101 Preclinical Data at the European Society for Medical Oncology (ESMO) Congress 2022

ST. LOUIS & SAN DIEGO–(BUSINESS WIRE)–Wugen, Inc., a clinical-stage biotechnology company developing a pipeline of allogeneic cell therapies to treat a broad range of hematological and solid tumor malignancies, today announced it will present preclinical data on WU-NK-101, the company’s lead memory natural killer (NK) cell therapy product, at the European Society for Medical Oncology … [Read more…]

Zymeworks Announces Release of ESMO Abstract for Phase 1 Study of Zanidatamab Zovodotin (ZW49) in Solid Cancers

Zanidatamab zovodotin shown to have manageable safety profile with encouraging, single-agent anti-tumor activity in patients with HER2+ cancers Results to be reviewed in an oral presentation at European Society for Medical Oncology (ESMO) Congress 2022 in Paris Monday, September 12 at 5:25 pm Central European Summer Time (CEST) VANCOUVER, British Columbia & SEATTLE–(BUSINESS WIRE)–Zymeworks Inc. … [Read more…]

New TROPiCS-02 Data in HR+/HER2- Metastatic Breast Cancer Patients Demonstrates Progression-Free Survival Benefit of Trodelvy® Regardless of Their HER2 Status

— Progression-Free Survival Efficacy of Trodelvy Consistent with That Observed in the TROPiCS-02 Intention-to-Treat Population — — Results Presented at ESMO 2022 Highlight Trodelvy as a Potential Treatment Option in HR+/HER2-Low and IHC0 Status Metastatic Breast Cancer — FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today announced new data from a post hoc subgroup … [Read more…]

Blade Therapeutics Presents Analyses from Phase 1 and Preclinical Studies of Cudetaxestat at the European Respiratory Society International Congress 2022

In Phase 1 studies, cudetaxestat displayed low potential for drug-drug interactions when dosed with approved therapies for idiopathic pulmonary fibrosis (IPF) and other commonly used medications Cudetaxestat was well tolerated and showed no reports of treatment-related serious adverse events, including when co-administered with either pirfenidone or nintedanib, in healthy volunteers Cudetaxestat, an investigational non-competitive autotaxin … [Read more…]

Fresenius Kabi and AABB Celebrate 17th Annual Blood Collectors Week from September 4-10, 2022

Honoring blood collection professionals and their lifesaving impact on patient care LAKE ZURICH, Ill. & BETHESDA, Md.–(BUSINESS WIRE)–#BloodCollectorsWeek–Fresenius Kabi and AABB announced today the official start of the 17th annual Blood Collectors Week celebration, which runs September 4-10, 2022. Throughout the week, blood collectors are being honored for the lifesaving work they do each day … [Read more…]

CONVERT Clinical Trial Data Presented at ERS Demonstrates Early Success of AeriSeal System in Patients with Advanced COPD/Emphysema

The reported data suggest that patients with collateral ventilation may be able to undergo successful treatment with Zephyr Endobronchial Valves following closure of collateral air channels with the AeriSeal System REDWOOD CITY, Calif. & BARCELONA, Spain–(BUSINESS WIRE)–$LUNG #COPD–Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, announces the … [Read more…]

Pure Health, UAE’s Largest Healthcare Platform, Signs a Deal With Equity Group Investments to Invest Half a Billion Dollars in a U.S. Healthcare Company

$500m investment expands Pure Health’s footprint in the United States healthcare market. Ardent Health Services is the fourth largest private hospital operator in the United States with operations across six states. CHICAGO–(BUSINESS WIRE)–Alpha Dhabi Holding subsidiary, Pure Health, the largest integrated healthcare platform of the United Arab Emirates (UAE), today announced that it has entered … [Read more…]

NanoVibronix Announces Receipt of Nasdaq Listing Determination; Company to Request Hearing

ELMSFORD, N.Y.–(BUSINESS WIRE)–NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that, on August 30, 2022, the Company received notice from the Nasdaq Listing Qualifications Staff (the “Staff”) indicating that, based upon the Company’s continued non-compliance with Nasdaq’s minimum bid price … [Read more…]

Pioneering Radiology Center Opens in New Jersey, Announces ImageCare Radiology

JEFFERSON, N.J.–(BUSINESS WIRE)–#3DMammogram–A pioneering, state-of-the-art radiology center in New Jersey has officially announced its opening date to the public this month. Set to improve and redefine the medical diagnostic imaging experience for its patients, the new ImageCare Radiology location in Jefferson was launched on September 1, 2022 and will provide the most advanced medical diagnostic … [Read more…]

WHO Backs Safer Sex Against Monkeypox, says AHF

LOS ANGELES–(BUSINESS WIRE)–The World Health Organization (WHO) recommended the use of condoms as a means of preventing potential monkeypox infections this week, following reports that viral DNA has been found in semen. The guidance comes several weeks after AIDS Healthcare Foundation first highlighted the importance of barrier protection for high-risk groups to reduce the risk … [Read more…]